MENU
FHTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Foghorn Therapeutics (FHTX) Ownership - Who owns Foghorn Therapeutics?
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system... Show more
Profile
Industry
N/A
Address
500 Technology Square
Phone
+1 617 586-3100
Employees
116
Web
https://www.foghorntx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
235.8M
P/E Ratio
N/A
Total Cash
243.75M
Projected Growth
N/A
Total Debt
37.13M
Revenue
22.6M
Risk (Beta)
3.09
Dividend Yield
N/A
Total Cash/Share
4.38
Total Debt/Equity
N/A
Revenue/Share
0.41 USD as % of share price
Fundamentals
FHTX
Capitalization
236M
P/E Ratio
N/A
Risk (Beta)
3.09
Dividend Yield
N/A
Total Cash
244M
Total Cash/Share
4.38
Total Debt
37.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.41%
Revenue
22.6M
ROE
N/A
Book Value
-45.53M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-1.58
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
3.73
Current Revenue Per Employee
25500.00
Dividends Per Share - Security
N/A
EBITDA
-97.17M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-30.40
Shares Held By Institutions
251M
Shares Outstanding - Current
55.6M
Total Liabilities
330M
Total Volume MTD
N/A
Value
-1
Gain YTD
-0.847
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
500 Technology Square
Phone
+1 617 586-3100
Employees
116
Web
https://www.foghorntx.com